Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In the equivalent trial for Tirzepatide (the active ingredient in Mounjaro), non-response rates were slightly lower, with around 9 to 11% of participants not reaching the 5% threshold at the two highest doses over 72 weeks (2)
10.1016/j.ophtha.2025.02.011 66 VilsbllT.BainS
Rotating injection sites and ensuring proper injection technique can reduce these reactions
A small note before you decide The patterns above reflect consistent themes across multiple independent discussions, rather than any single perspective
Risks: Potential for burns, redness, and sensitivity
The key difference is retatrutide's dysesthesia (20.9%) versus less than 1% with Wegovy or Mounjaro
US$ 26.01
US$ 25.53
US$ 24.95
US$ 25.16
